{"id":"hydroxypropyl-guar","_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Hydroxypropyl Guar","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:08:33.587194+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:08:46.159006+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Hydroxypropyl Guar","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:08:46.939644+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108446/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:08:47.807645+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-27T23:41:09.705Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:08:49.831918+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT07243275","phase":"PHASE4","title":"SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease","status":"RECRUITING","sponsor":"Indiana University","startDate":"2026-02-18","conditions":"Dry Eye Disease (DED)","enrollment":260},{"nctId":"NCT06784661","phase":"PHASE4","title":"Immediate Effects of Lipid-Based and Non-Lipid Artificial Tears on Corneal Aberrations","status":"NOT_YET_RECRUITING","sponsor":"University of Seville","startDate":"2025-02-01","conditions":"Aberration, Corneal Wavefront","enrollment":40},{"nctId":"NCT06505174","phase":"","title":"Effect of Treatment With Systane Ultra in Symptomatology and Visual Task Efficiency in Digital Device Users","status":"COMPLETED","sponsor":"University of Valladolid","startDate":"2023-01-10","conditions":"Digital Eye Strain, Computer Vision Syndrome, OSDI","enrollment":34},{"nctId":"NCT06209879","phase":"PHASE4","title":"Dual-Polymer Hydroxypropyl Guar-and Hyaluronic Acid Lubricants in Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2024-02-05","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT06221345","phase":"PHASE4","title":"Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-12-07","conditions":"Dry Eye Disease, Cataract","enrollment":70},{"nctId":"NCT05139966","phase":"PHASE2, PHASE3","title":"Fluoride Controlled-release System for Initial Lesions of Caries","status":"COMPLETED","sponsor":"Federal University of Paraíba","startDate":"2017-08-03","conditions":"White Spot Lesion","enrollment":21},{"nctId":"NCT03223909","phase":"PHASE4","title":"Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2016-10-13","conditions":"Dry Eye Syndrome","enrollment":326},{"nctId":"NCT01541891","phase":"PHASE2","title":"Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2011-10","conditions":"Dry Eye Syndrome","enrollment":30},{"nctId":"NCT00843466","phase":"NA","title":"Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2007-05","conditions":"Hand Dermatosis","enrollment":46},{"nctId":"NCT01657253","phase":"PHASE3","title":"Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2013-11","conditions":"Dry Eye","enrollment":183},{"nctId":"NCT03157193","phase":"PHASE4","title":"Effect of Hyaluronic Acid on Perimplantitis","status":"COMPLETED","sponsor":"Universidad de Granada","startDate":"2014-09","conditions":"Peri-Implantitis","enrollment":61},{"nctId":"NCT00840268","phase":"PHASE2","title":"A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye Patients","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2009-02","conditions":"Dry Eye","enrollment":427},{"nctId":"NCT00681265","phase":"NA","title":"Tear Film Break-up Time After Instillation of Artificial Tears","status":"COMPLETED","sponsor":"Calm Water Therapeutics LLC","startDate":"2008-06","conditions":"Keratoconjunctivitis Sicca","enrollment":16},{"nctId":"NCT01268735","phase":"PHASE4","title":"The Effect of Ocular Lubricant Eyedrops on Lid Parallel Conjunctival Folds and Other Signs and Symptoms of Dry Eye","status":"COMPLETED","sponsor":"University of Zagreb","startDate":"2009-04","conditions":"Dry Eye Syndromes","enrollment":229},{"nctId":"NCT00760045","phase":"PHASE2","title":"Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2008-08","conditions":"Dry Eye Disease","enrollment":40}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"DRY EYE"},{"count":1,"reaction":"BLADDER CANCER"},{"count":1,"reaction":"EYE IRRITATION"},{"count":1,"reaction":"EYE SWELLING"}],"crossReferences":{"chemblId":"CHEMBL2108446"},"_approvalHistory":[],"publicationCount":137,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Control 1"],"phase":"marketed","status":"active","brandName":"Hydroxypropyl Guar","genericName":"Hydroxypropyl Guar","companyName":"Universidad de Granada","companyId":"universidad-de-granada","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:08:49.831918+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}